Viewing Study NCT06394518


Ignite Creation Date: 2025-12-25 @ 4:51 AM
Ignite Modification Date: 2025-12-26 @ 3:52 AM
Study NCT ID: NCT06394518
Status: COMPLETED
Last Update Posted: 2024-05-01
First Post: 2024-04-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Phase 1, Single-Dose and Multiple-Dose Continuous Intravenous Infusions of TNP-2092 for Injection in Healthy Chinese Participants
Sponsor: TenNor Therapeutics Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module